Agilent Technologies Delivers a Clinical Beat, with Pharma Strength and Tariff Insulation Anchoring the Outlook —What’s Driving the Valuation Disconnect & Can EPS Normalization Catch Up?

$50.00 — or $120.00 / year

Agilent posted a strong Q2FY25, with revenue of $1.67B (+6% reported, +5.3% core) and EPS of $1.31 (+7%), marking a fourth straight quarter of accelerating growth. CrossLab led with +9% growth, bolstered by services, automation, and +12% digital orders. PFAS testing surged >70% YoY, now a $100M+ run-rate, with secular tailwinds extending growth visibility. Life Sciences & Diagnostics (+3%) saw strength in Pathology and LC/LCMS, while Applied Markets was flattish, though PFAS demand offset softness elsewhere. Ignite-driven cost efficiencies ($50M procurement, $80M organizational savings), 100bps YTD pricing gains, and proactive tariff mitigation underpinned margin resilience, absorbing $60M in tariff headwinds while maintaining full-year EPS guidance ($5.54–5.61). NASD/BIOVECTRA integration progresses well, with NASD poised for 2H25 acceleration and BIOVECTRA scaling GLP-1 capacity, enhancing Agilent’s advanced therapeutics positioning. Risks include uneven biopharma spend and U.S. academic/government funding headwinds (–2% sales). PFAS momentum, the LC replacement cycle, and margin expansion via Ignite remain key growth levers, while pharma onshoring offers long-term upside. Despite solid execution, shares remain undervalued versus our long-term model (6% rev, 7% FCF, 10% EPS CAGR through 2029), as macro noise obscures fundamentals. Can Agilent sustain its EPS normalization trajectory and unlock valuation convergence amid sector volatility and tariff crosswinds?

Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures

Related products

  • Bruker (BRKR): Can Dual Strategy of Project Accelerate 2.0 and Acquisitions Drive Explosive Growth to Updated Targets? Out of stock

    Bruker (BRKR): Can Dual Strategy of Project Accelerate 2.0 and Acquisitions Drive Explosive Growth to Updated Targets?

     Read more
  • Nextracker Inc. (NXT): Increasing Competition May Impact Pricing & Margins,BUT Heres Why Growth is On-Track and Unwavering!

    Nextracker Inc. (NXT): Increasing Competition May Impact Pricing & Margins,BUT Heres Why Growth is On-Track and Unwavering!

     $50.00 — or $120.00 / year

    Nextracker has provided a positive outlook for fiscal year 2025, projecting continued growth in revenue and profitability. The company expects revenue in the range of $2.8 billion to $2.9 billion, representing approximately 14% year- over-year growth at the midpoint. Adjusted EBITDA is forecasted to be between $600 million and $650 million, implying a 20% growth year-over-year. The expected GAAP EPS ranges from $2.41 to $2.61 per share, while adjusted EPS is projected to be between $2.89 and $3.09 per share. Nextracker’s guidance reflects its confidence in its strategic initiatives and strong backlog, with over $4 billion in contracted bookings supporting the fiscal year 2025 outlook. In conclusion, Nextracker’s fiscal year 2024 performance underscores its robust market position and strategic execution. The company achieved significant growth in revenue, profitability, and backlog, driven by strong demand for its solar tracking solutions and strategic global expansion. Nextracker’s focus on innovation, quality, and reliability has enabled it to deliver superior financial returns for customers and establish itself as a leader in the renewable energy sector. While challenges such as market competition, regulatory changes, and supply chain complexities persist, Nextracker’s strong financial position and strategic initiatives position it well for continued growth. Given the positive outlook for fiscal year 2025, with projected increases in revenue and EBITDA, Nextracker is poised to capitalize on the expanding solar energy market.

    Select options This product has multiple variants. The options may be chosen on the product page
  • Palo Alto Networks (PANW): No Sweat! The Role of AI, Platformization, and Key Drivers in Achieving $15B ARR! Out of stock

    Palo Alto Networks (PANW): No Sweat! The Role of AI, Platformization, and Key Drivers in Achieving $15B ARR!

     Read more
Scroll to Top